Abstract
Public health and epidemiologic research have established that social connectedness promotes overall health. Yet there have been no recent reviews of findings from research examining social connectedness as a determinant of mental health. The goal of this review was to evaluate recent longitudinal research probing the effects of social connectedness on depression and anxiety symptoms and diagnoses in the general population. A scoping review was performed of PubMed and PsychInfo databases from January 2015 to December 2020 following PRISMA-ScR guidelines using a defined search strategy. The search yielded 56 articles representing 52 unique studies. In research with other than pregnant women, 84% (16 of 19) studies reported that social support benefited symptoms of depression with the remaining 16% (3 of 19) reporting minimal or no evidence that lower levels of social support predict depression at follow-up. In research with pregnant women, 80% (21 of 26 studies) found that low social support increased postpartum depressive symptoms. Among 3 of 4 studies that focused on loneliness, feeling lonely at baseline was related to adverse outcomes at follow-up including higher risks of major depressive disorder, depressive symptom severity, generalized anxiety disorder, and lower levels of physical activity. In 5 of 7 reports, smaller social network size predicted depressive symptoms or disorder at follow-up. In summary, most recent relevant longitudinal studies have demonstrated that social support protects adults in the general population from depressive symptoms and disorders. The results, which were largely consistent across settings, exposure measures, and populations, support efforts to improve clinical detection of high-risk patients, including adults with low social support and elevated loneliness.
Competing Interest Statement
The authors have no competing interests with regard to this study. Dr. Jyotishman Pathak is cofounder of Iris OB Health Inc., and has equity ownership. Dr. John Mann receives royalties from the Research Foundation for Mental Hygiene for commercial use of the C-SSRS. Dr. Myrna M. Weissman has received research funding from NIMH, Brain and Behavior Foundation, Templeton Foundation and has received book royalties from Perseus Press, Oxford Press, and APA Publishing and receive royalties on the social adjustment scale from Multihealth Systems. None of these represent a conflict of interest. Funding: This work was supported by the National Institute of Mental Health - R0 1 MH121924: Leveraging EHR -linked biobanks for deep phenotyping polygenic risk score modelling, and outcome analysis in psychiatric disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Acquisition: MMW, JP
Funding Statement
Funding: This work was supported by the National Institute of Mental Health - R0 1 MH121924: Leveraging EHR -linked biobanks for deep phenotyping polygenic risk score modelling, and outcome analysis in psychiatric disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Acquisition: MMW, JP
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yes - all data are fully available without restriction
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Yes - all data are fully available without restriction